Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- ALR Technologies Receives Notice From US Patent Office That Patent Protection Covering Several of Their Products Has Been Allowed
- ALR Technologies Inc. (OTC BB: ALRT), headquartered in Winston-Salem, NC, announced today it has been notified by the US Patent and Trademark Office that patent protection covering important elements of many of their disease management reminder products has been allowed and will soon issue.
- Research articles 2005-02-10
- Ecopia Obtains Patent Protection on ECO-4601 from the USPTO
- MONTREAL -- Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce it has received a Notice of Allowance from the United States Patent and Trade-mark Office ("USPTO") for a patent application directed to ECO-4601, the Company's lead anticancer compound that is in preparation for its Phase I clinical trials. The allowed...
- Research articles 2005-12-07
- Ecopia Obtains Patent Protection on ECO-4601 from the USPTO.
- MONTREAL, QUEBEC, Dec 7, 2005 CCNMatthews via COMTEX -- Ecopia BioSciences Inc. (TSX:EIA) is pleased to announce it has received a Notice of Allowance from the United States Patent and Trade-mark Office ("USPTO") for a patent application MONTREAL, QUEBEC, Dec 7, 2005 CCNMatthews via COMTEX...
- Research articles 2005-12-07
- Patent protection; Companies battle to defend hard-won discoveries from encroachment.(Rubicon Technology Inc., Cobotics Inc., NanoInk Inc.)(Statistical Data Included)
- NanoInk Inc., a new Chicago-based nanotechnology company, would like to be the house that patents built, says CEO Chris Anzalone. But first, it must build a foundation of intellectual property protection for its high-tech inventions. The company o NanoInk Inc., a new Chicago-based...
- Research articles 2002-07-08
- Ecopia Announces that the USPTO Confirms Patent Protection on ECO-4601's Composition of Matter Claims
- Ecopia (TSX: EIA) is pleased to announce that The United States Patent and Trademark Office USPTO has confirmed allowance of US patent application USSN 10/762,107, including notably the composition-of-matter claims directed to Ecopia's lead drug candidate ECO-4601. In 2005, the USPTO had issued a first Notice of Allowance for...
- Research articles 2006-07-13
Additional Resources
- Bavarian Nordic, Danish Biopharmaceutical Firm, Issued U.S. Patent on MVA
- WASHINGTON, July 5 /U.S. Newswire/ -- Bavarian Nordic, the Denmark- based biopharmaceutical company that is developing a new, safer vaccine for protection against smallpox, announced today that it has received another patent from the U.S. Patent and Trademark Office, further strengthening its intellectual property position on MVA. The new patent...
- Research articles 2005-07-05
- Russian Government Suffers Defeat in Use of Trade Name for Flagship International TV Network; Russia Today Television Denied Application by U.S. Patent & Trademark Office
- To: BUSINESS EDITORSContact: David Rothstein of IPD Group, +1-202-318-8905 or http:// www.ipdgroup.com/feedback.php WASHINGTON, May 2 /PRNewswire-USNewswire/ -- The Russian government's attempts at building an International TV News franchise suffered a setback as the United States Patent and Trademark Office rejected its bid to gain trademark protection for the use of...
- Research articles 2007-05-02
- Aseptic Gravity Flow Valve Technology Receives Notification Of Utility Patent From U.S. Patent & Trademark Office; Aseptic Dispensing Technology Opens New Markets Worldwide.
- MILLERSVILLE, MARYLAND, Jul 26, 2002 International Dispensing Corporation IDC (OTCBB:IDND) announced today that the U.S. Patent and Trademark Office has allowed IDC's utility patent application for its Aseptic Gravity Flow Valvetm. The allowance by the U.S. Patent Office provides extensive and ...
- Research articles 2002-07-26
- Aseptic Gravity Flow Valve Technology Receives Notification of Utility Patent from U.S. Patent & Trademark Office; Aseptic Dispensing Technology Opens New Markets Worldwide
- Business Editors MILLERSVILLE, Md.--BUSINESS WIRE--July 26, 2002 International Dispensing Corporation IDC (OTCBB:IDND) announced today that the U.S. Patent and Trademark Office has allowed IDC's utility patent application for its Aseptic Gravity Flow ValveTM. The allowance by the U.S. Patent Office provides extensive and broad-based coverage for IDC's...
- Research articles 2002-07-26
- U.S. Patent Office Allows Hythiam Patent Application Underlying the PROMETA Treatment Program for Alcoholism
- LOS ANGELES -- Hythiam, Inc. (NASDAQ:HYTM) announced today that the United States Patent and Trademark Office has allowed Hythiam's U.S. Patent Application No. 10/621,229 which contains claims using a composition of matter for reducing a person's desire to drink alcohol. The patent will serve to enhance protection of the intellectual...
- Research articles 2008-01-10
- U.S. Patent Office Provides Notice of Allowance for Hythiam Patent Application for the Treatment of Cocaine Dependency
- LOS ANGELES -- Hythiam, Inc. (NASDAQ:HYTM), a healthcare services management company that licenses the PROMETA([R])treatment protocols designed to treat alcohol, methamphetamine and cocaine dependence, announced today that the United States Patent and Trademark Office has mailed a Notice of Allowance for Hythiam's U.S. Patent Application No. 10/622,068 which contains claims...
- Research articles 2006-12-14
- Scott Smith files notice with U.S. Patent Office, accusing Entrepreneur magazine of fraud.
- Latest battle in long war over magazine's protection of a word The U.S. Patent Office granted a trademark on the word entrepreneur to Entrepreneur Media Inc., publisher of Entrepreneur magazine, in 1982, before it became today's common word. The company has aggressively protected its...
- Research articles 2007-11-09
- Trilateral European, Japanese and U.S. Patent Symposium to be Held in Munich.
- MUNICH, Germany, November 11 /PRNewswire/ -- The partnership between the European Patent Office, the Japan Patent Office JPO and the United States Patent and Trademark Office UPTO is in many respects the driver of the international patent system. Although a ...
- Research articles 2005-11-11
- MethylGene Strengthens U.S. Patent Portfolio in Antibiotic Resistance
- MONTREAL -- U.S. patent for compounds to overcome beta-lactamase mediated antibiotic resistance MethylGene Inc. (TSX:MYG), a biopharmaceutical company, today announced that the United States Trademark and Patent Office has issued U.S. Patent #6,884,791 on April 26, 2005 entitled "Novel Inhibitors of Beta-Lactamase," which provides protection for...
- Research articles 2005-04-27
- Atrix to be issued additional U.S. patent for BEMA Technology.
- M2 PRESSWIRE-11 April 2000-ATRIX LABORATORIES: Atrix to be issued additional U.S. patent for BEMA Technology C1994-2000 M2 COMMUNICATIONS LTD RDATE:10042000 FORT COLLINS, Colorado -- Atrix Laboratories, Inc. (Nasdaq NM: ATRX) announced that the U.S. Patent and Trademark Office has issued a...
- Research articles 2000-04-11
- Cereplast Compostables® Resins Granted U.S. Patent for Composition
- HAWTHORNE, Calif. -- Cereplast, Inc. (OTCBB: CERP), manufacturer of proprietary bio-based, sustainable plastics, secured patent protection for its Cereplast Compostable([R]) resin family of products from the United States Patent and Trademark Office USPTO. The U.S. patent (#7,393,590) was issued on July 1, 2008 and adds to the company's intellectual capital....
- Research articles 2008-07-02
- MethylGene Strengthens U.S. Patent Portfolio in Antibiotic Resistance.
- MONTREAL, QUEBEC, Apr 27, 2005 CCNMatthews via COMTEX MethylGene Inc. (TSX:MYG) U.S. patent for compounds to overcome beta-lactamase mediated antibiotic resistance MethylGene Inc. (TSX:MYG), a biopharmaceutical company, today announced that the United States Trademark and Patent Office has issued...
- Research articles 2005-04-27
- Adnexus Therapeutics Announces Issuance of U.S. Patent for Broad Protection of New Therapeutic Class, Adnectins™
- WALTHAM, Mass. -- Adnexus TherapeuticsTM, Inc. announced today that the United States Patent and Trademark Office USPTO has granted U.S. Patent No. 7,115,396 with broad composition of matter claims to AdnectinTM proteins. Exclusively owned by Adnexus, this patent further expands the company's ownership of Adnectins, a class of targeted biologics...
- Research articles 2006-10-23
- Allstate Receives U.S. Patent Related To Treasury-Linked Annuities; Innovation Pays Off for Allstate, Producers and Consumers
- NORTHBROOK, Ill. -- Methods used in connection with Allstate's innovative deferred fixed annuity products, the AllstateR Treasury-Linked Annuity (T-Link) and AllstateR Treasury-Linked Annuity Plus (T-Link Plus), are now subject to patent protection through a patent issued to Allstate by the U.S. Patent and Trademark Office. Allstate first introduced T-Link in...
- Research articles 2006-08-30
- Xenomics Files U.S. Patent on Breakthrough Tuberculosis Diagnostic Test Based on Its Proprietary Transrenal-DNA Platform; Company Expands Intellectual Property Portfolio with Latest Application of Innovative Molecular Diagnostics Technology
- NEW YORK -- Xenomics, Inc. (OTCBB:XNOM), a developer of next-generation medical DNA technologies, announced today that it has filed a US patent for breakthrough technology enabling the improved detection of tuberculosis based on its proprietary Transrenal DNA (Tr-DNA) technology which uses simple, easily obtained urine samples. This application with the...
- Research articles 2005-06-01
- << Previous
- page 1 of 1
- Next >>
